Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

GeoVax completes enrollment in phase I/II trial for HIV/AIDS vaccine

Jan. 14, 2013

Tobira Therapeutics reports data from phase IIb cenicriviroc trial

Jan. 10, 2013

Takara Bio begins phase I trial of HIV-1 gene therapy

Jan. 10, 2013

Clinical evaluation of the safety and tolerability of HIV vaccine alternative

Jan. 8, 2013

Novel HIV vaccine adjuvants created by French investigators

Jan. 7, 2013

ViiV Healthcare files for approval of dolutegravir

Dec. 19, 2012

Biotron's BIT-225 completes proof-of-concept trial in HIV

Dec. 17, 2012

Regulatory approvals received for new study of Vacc-4x

Dec. 7, 2012

Japan Tobacco applies for approval of single-tablet anti-HIV regimen in Japan

Dec. 7, 2012

Phase I study confirms safety and immunogenicity of HIV vaccine

Dec. 5, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 6, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...